Anti-MRSA agent 28
Anti-MRSA agent 28 is an antibacterial agent against multidrug resistant (MDR) gram-positive strains with MICs of 0.06-0.125 μg/mL. Anti-MRSA agent 28 can target DNA polymerase IIIC to reduce the amount of genomic DNA with the IC50 of 3.80 μg/mL. Anti-MRSA agent 28 has good antibacterial activity and reduces inflammation. Anti-MRSA agent 28 can be used against gram-positive strains and infectious conditions.
For research use only. We do not sell to patients.
- CAS No.: 2222727-47-9
- Formula: C27H22ClN3O5
- Molecular Weight:503.93
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
Description
IC50 & Target
|
DNA Polymerase |
In Vitro
Anti-MRSA agent 28 (Compound 5a) shows antibacterial activity against the Gram-positive strains, including S. aureus ATCC 33591 (MIC = 0.125 μg/mL), ATCC 700698 (MIC = 0.125 μg/mL), ATCC 700699 (MIC = 0.06 μg/mL) and ATCC BAA1708 (MIC = 0.125 μg/mL) [1].
Anti-MRSA agent 28 (0.25 μg/mL-4 μg/mL; 0 h-24 h) has antibacterial activity against S. aureus ATCC 33591[1].
Anti-MRSA agent 28 (1 μg/mL; 1 h) might inhibit the dysfunction of genomic DNA[1].
Anti-MRSA agent 28 (0.5 μg/mL-4.5 μg/mL) effectively influence the quantity of genomic DNA[1].
Anti-MRSA agent 28 (6.25 μM-50 μM) can dose-dependently bond to immobilized DNA Pol IIIC with the KD of 8.45 μM[1].
Anti-MRSA agent 28 (0 μg/mL-16 μg/mL) inhibits the DNA Pol IIIC of S. aureus ATCC 33591[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:The infection model was constructed by adding a droplet (20 μL) of 9 lg10 CFU/mL of S. aureus ATCC 33591 on the wound surface of the female BALB/c mouse (8 weeks)[1].
-
Dosage:2 % in vaseline
-
Administration:Apply medication
-
Result:Significantly lowered serum levels of pro-inflammatory cytokines: interleukin IL-1β, IL-6, TNF-α and C-reactive protein and effectively alleviated the necrosis.
Chemical Information
-
CAS No. 2222727-47-9
-
Molecular Weight 503.93
-
Formula C27H22ClN3O5
-
SMILES
COC1=C(C2=C(C3=C4C5=C(C6=C(OCO6)C=C5CC[N+]4=C2)C=C3)C=C1)OC(C7=CC(C)=NN7C)=O.[Cl-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Protocol for Southern Blot
Southern blot is a DNA hybridization assay used to detect a defined DNA sequence within restriction-digested or otherwise fragmented genomic DNA. The method separates DNA fragments by agarose gel electrophoresis, transfers the size-resolved DNA pattern onto a solid support, denatures the DNA to permit base pairing, and detects fragments that hybridize with a complementary labeled probe; the readout is a band, smear, or fragment-size distribution corresponding to the target sequence and its restriction-fragment context. The assay reflects sequence presence, restriction fragment length, gene copy pattern, structural rearrangement, insertion or deletion affecting restriction sites, and some repeat-length or terminal restriction fragment applications when the experimental design links the probe to those genomic features. Classic applications include Southern blot-based telomere terminal restriction fragment analysis and minisatellite-based DNA fingerprinting, which illustrate how the same
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)